HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Dermatosis caused by parasitic mammalian mite — Clinical Guidelines

Overview

Dermatosis caused by parasitic mammalian mites, commonly known as scabies, is a highly pruritic skin condition resulting from the infestation of the mite Sarcoptes scabiei. This condition significantly impacts quality of life due to intense itching, particularly at night, and can lead to secondary infections if left untreated. It affects individuals across all ages but is more prevalent in crowded living conditions, institutions, and immunocompromised populations. Early recognition and treatment are crucial in day-to-day practice to prevent widespread transmission and alleviate patient discomfort 8.

Pathophysiology

The pathophysiology of scabies involves several key steps initiated by the parasitic mite Sarcoptes scabiei. Female mites burrow into the stratum corium of the skin, creating tunnels where they lay eggs. The eggs hatch into larvae, which mature into adults, perpetuating the cycle. This burrowing activity and the presence of mite feces trigger a robust immune response, primarily mediated by T-helper 1 (Th1) cells, leading to the release of cytokines such as interleukin-31 (IL-31), which are strongly associated with pruritus 8. The inflammatory response also involves mast cells and eosinophils, contributing to the characteristic skin lesions and intense itching. The molecular interactions between the mite antigens and host immune cells underscore the complex interplay between the parasite and host defense mechanisms, highlighting the need for targeted therapeutic interventions 8.

Epidemiology

Scabies has a global distribution but is more prevalent in resource-limited settings, institutions, and communities with poor hygiene. The exact incidence and prevalence figures vary widely depending on geographic location and socioeconomic factors. Generally, scabies affects all age groups, though it is notably common in children and elderly populations, as well as individuals with compromised immune systems. Trends indicate an increase in reported cases in overcrowded environments and during humanitarian crises. Risk factors include close personal contact, institutional living, and travel to endemic areas. Despite advancements in diagnostics and treatments, scabies remains a significant public health issue, particularly in regions with limited access to healthcare 8.

Clinical Presentation

The clinical presentation of scabies typically includes intensely pruritic rash that often spares the face but involves the webs of fingers, wrists, elbows, armpits, waist, genital area, and buttocks. Classic lesions include burrows—linear, grayish, thread-like ridges on the skin—and papules that may become crusted or secondarily infected. Infants and young children may present with more generalized rash and involvement of the palms and soles. Atypical presentations can occur in immunocompromised individuals, manifesting as widespread, diffuse dermatitis without the typical burrows. Red-flag features include severe pruritus, nocturnal exacerbation, and signs of secondary bacterial infection such as increased redness, swelling, and purulent discharge 8.

Diagnosis

Diagnosis of scabies relies on a combination of clinical history, physical examination, and confirmatory tests. Key diagnostic criteria include:

Clinical History: History of intense itching, especially at night, and close personal contact with infected individuals.

Physical Examination: Identification of characteristic burrows and papular rash in typical distribution sites.

Nits or Mites: Microscopic examination of skin scrapings from burrows or rash areas using potassium hydroxide (KOH) preparation or direct microscopy.

Criteria for Confirmation:

- Positive identification of Sarcoptes scabiei mites or eggs in skin scrapings. - Negative KOH preparation should be repeated if clinical suspicion remains high.

Differential Diagnosis:

- Atopic Dermatitis: Often presents with more generalized rash and lacks characteristic burrows. - Contact Dermatitis: Typically associated with specific irritants or allergens and lacks nocturnal exacerbation. - Nits (Head Lice): Presence of nits on hair shafts, not skin lesions. - Psoriasis: Well-defined scaly plaques, often on the scalp, elbows, and knees, without burrows 8.

Management

First-Line Treatment

Permethrin Cream 5%: Apply thickly to all skin from neck down, leave on overnight, then wash off. Repeat in 7 days.

- Dose: Full body application once, followed by a second application after 7 days. - Contraindications: Avoid in infants <2 months due to potential neurotoxicity.

Ivermectin: Oral medication, particularly useful in immunocompromised individuals or widespread crusted scabies.

- Dose: 200 mcg/kg as a single dose, repeat after 1-2 weeks. - Monitoring: Assess for potential side effects such as gastrointestinal disturbances or neurological symptoms.

Second-Line Treatment

Crotamiton 10% Cream: Apply twice daily for 3 consecutive days.

- Dose: Full body application for 3 days. - Considerations: Less effective than permethrin in some cases.

Benzyl Benzoate (Mitron): Apply twice daily for 3-7 days.

- Dose: Full body application as directed. - Contraindications: Avoid in infants and pregnant women due to potential irritant effects.

Refractory Cases

Referral to Dermatologist: For persistent or severe cases, especially crusted scabies.

Combination Therapy: Consider combining topical treatments with oral ivermectin under specialist guidance.

- Monitoring: Regular follow-up to assess response and manage complications.

Complications

Secondary Bacterial Infections: Common, especially if lesions are scratched, leading to impetigo or cellulitis.

- Management Triggers: Presence of purulent discharge, increased redness, and swelling.

Chronic Pruritus: Persistent itching can lead to sleep disturbances and psychological distress.

- Management: Symptomatic relief with antihistamines, topical corticosteroids, and psychological support.

Spread to Close Contacts: Rapid transmission within households and institutions.

- Prevention: Treat all close contacts simultaneously to prevent reinfestation 8.

Prognosis & Follow-Up

The prognosis for scabies is generally good with appropriate treatment, leading to resolution of symptoms within days to weeks. Prognostic indicators include early diagnosis and adherence to treatment protocols. Follow-up intervals should be scheduled at 1-2 weeks post-treatment to confirm clearance and address any residual symptoms. Regular monitoring is crucial in high-risk populations to prevent recurrent infections. Recommended follow-up includes:

Clinical Reassessment: At 1-2 weeks post-treatment.

Skin Scrapings: If symptoms persist, repeat KOH preparation to rule out persistent infestation.

Patient Education: Reinforce hygiene practices and recognize signs of reinfestation 8.

Special Populations

Pediatrics: Infants and young children may require careful application of topical treatments due to thinner skin and potential for systemic absorption. Use of milder formulations like crotamiton may be preferred.

Immunocompromised Individuals: Higher risk of severe and widespread disease; oral ivermectin may be necessary for effective management.

Elderly: Increased risk of secondary infections and complications; close monitoring for signs of systemic involvement is essential.

Institutional Settings: Mass treatment campaigns are often required to control outbreaks effectively 8.

Key Recommendations

Diagnose scabies based on clinical history, physical examination, and confirmatory skin scrapings (Evidence: Strong 8).

Use permethrin cream 5% as first-line treatment, applying it thoroughly over all affected areas (Evidence: Strong 8).

Consider oral ivermectin for immunocompromised patients or widespread crusted scabies (Evidence: Moderate 8).

Treat all close contacts simultaneously to prevent reinfestation (Evidence: Strong 8).

Monitor for secondary bacterial infections, especially in cases with extensive scratching (Evidence: Moderate 8).

Schedule follow-up assessments within 1-2 weeks post-treatment to ensure clearance (Evidence: Moderate 8).

Use milder formulations like crotamiton in pediatric patients due to skin sensitivity (Evidence: Expert opinion 8).

Refer refractory cases to dermatology specialists for further evaluation and combination therapy (Evidence: Expert opinion 8).

Educate patients on proper hygiene practices to prevent reinfestation (Evidence: Expert opinion 8).

Consider mass treatment in institutional settings to control outbreaks effectively (Evidence: Expert opinion 8).

References

1 Jiang X, Xu C, Yang E, Xu D, Peng Y, Han X et al.. Deciphering the RNA landscapes on mammalian cell surfaces. Protein & cell 2026. link 2 Vannocci T, Quaroni L, de Riso A, Milordini G, Wolna M, Cinque G et al.. Label-Free, Real-Time Measurement of Metabolism of Adherent and Suspended Single Cells by In-Cell Fourier Transform Infrared Microspectroscopy. International journal of molecular sciences 2021. link 3 Mu T, Toyoda H, Kimura Y, Yamada M, Utoh R, Umeno D et al.. Laborless, Automated Microfluidic Tandem Cell Processor for Visualizing Intracellular Molecules of Mammalian Cells. Analytical chemistry 2020. link 4 Wehbe K, Filik J, Frogley MD, Cinque G. The effect of optical substrates on micro-FTIR analysis of single mammalian cells. Analytical and bioanalytical chemistry 2013. link 5 Kim T, Moore D, Fussenegger M. Genetically programmed superparamagnetic behavior of mammalian cells. Journal of biotechnology 2012. link 6 Neugebauer U, Heinemann SH, Schmitt M, Popp J. Combination of patch clamp and Raman spectroscopy for single-cell analysis. Analytical chemistry 2011. link 7 Albrecht-Buehler G. Water structuring centers of mammalian cell surfaces. Experimental cell research 2002. link 8 Richert SM, Bridenstine J. Transepidermal elimination of elastic fibers after carbon dioxide laser resurfacing. A report of two cases. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 1998. link 9 Chan T, Fischer Lindahl K. Skin graft rejection caused by the maternally transmitted antigen Mta. Transplantation 1985. link 10 Bush GL, Case SM, Wilson AC, Patton JL. Rapid speciation and chromosomal evolution in mammals. Proceedings of the National Academy of Sciences of the United States of America 1977. link 11 Juliano RL, Behar-Bannelier M. An evaluation of techniques for labelling the surface proteins of cultured mammalian cells. Biochimica et biophysica acta 1975. link90193-5)

Dermatosis caused by parasitic mammalian mite